Abstract: A system for the repair of a ruptured tissue is provided. Aspects of the invention include a repair device comprising a combination of a scaffold and graft attached by one or more sutures to one or more fixation devices and inserted into a repair site via arthroscopic equipment or an open surgical procedure. The system may be used to treat tissue injuries including ruptured ligaments, tendons, and cartilage.

Abstract: Methods and system for the repair of a ruptured anterior cruciate ligament using a femoral attachment are provided. Aspects of the invention include a scaffold attached by a suture to an fixation device. The fixation device and suture are secured to a femur and not to a tibia near or at the repair site.

Abstract: An arthroscopic system for the repair of a ruptured anterior cruciate is provided. Aspects of the invention include a scaffold attached by a suture to an fixation device and inserted into a repair site via arthroscopic equipment. The scaffold and suture are further secured near or at the repair site via arthroscopic equipment having an elongated delivery member that contains the scaffold and suture prior to inserting the scaffold and suture into the repair site.

Abstract: Technologies are disclosed for an implant device that may be configured to repair tissue. The device may include a distal end configured to be connectable to at least a first part of the tissue. The device may include a proximate end configured to be connectable to at least a second part of the tissue. The device may include a substrate configured to form a connection between the first part of the tissue and the second part of the tissue. The device may include a longitudinal axis that may extend between the distal end to the proximate end within the substrate. The device may include at least one preformed channel in the substrate. The device may include at least one suture preloaded at least partially within the at least one channel. The at least one preformed channel may be formed during and/or proximate to a formation of the device.

Abstract: A method for coupling a body conduit to tissue includes engaging an implant about an outer surface of a catheter. The implant receives a bioactive agent having tissue growth properties. The method involves inserting the catheter through the body conduit and into a tissue opening across a resected area, positioning the implant in the resected area, inflating a balloon to anchor the catheter within the tissue opening such that the implant bridges the body conduit and the tissue opening across the resected area, and maintaining the catheter and the implant in vivo to enable the bioactive agent to secure the implant in the resected area to permanently bridge the body conduit and the tissue opening.

Abstract: A method for coupling a body conduit to tissue includes engaging an implant about an outer surface of a catheter. The implant receives a bioactive agent having tissue growth properties. The method involves inserting the catheter through the body conduit and into a tissue opening across a resected area, positioning the implant in the resected area, inflating a balloon to anchor the catheter within the tissue opening such that the implant bridges the body conduit and the tissue opening across the resected area, and maintaining the catheter and the implant in vivo to enable the bioactive agent to secure the implant in the resected area to permanently bridge the body conduit and the tissue opening.

Abstract: A method for coupling a body conduit to tissue is provided. The method includes engaging an implant about an outer surface of a catheter. The implant receives a bioactive agent having tissue growth properties. The method involves inserting the catheter through the body conduit and into a tissue opening across a resected area, positioning the implant in the resected area, inflating a balloon to anchor the catheter within the tissue opening such that the implant bridges the body conduit and the tissue opening across the resected area, and maintaining the catheter and the implant in vivo to enable the bioactive agent to secure the implant in the resected area to permanently bridge the body conduit and the tissue opening.

Abstract: A method for coupling a body conduit to tissue is provided. The method includes engaging an implant about an outer surface of a catheter. The implant receives a bioactive agent having tissue growth properties. The method involves inserting the catheter through the body conduit and into a tissue opening across a resected area, positioning the implant in the resected area, inflating a balloon to anchor the catheter within the tissue opening such that the implant bridges the body conduit and the tissue opening across the resected area, and maintaining the catheter and the implant in vivo to enable the bioactive agent to secure the implant in the resected area to permanently bridge the body conduit and the tissue opening.

Abstract: A catheter assembly for coupling a body conduit to tissue is provided. The catheter assembly includes a catheter and an implant selectively positionable about an outer surface of the catheter. The implant is configured to receive a bioactive agent having tissue growth properties. The implant is configured to act as a bridge between the body conduit and the tissue and is separable from the catheter assembly.

Abstract: A novel method of preparing a controlled release composition is disclosed. Specifically, the present invention relates to a method of preparing controlled release compositions of ascorbic acid phosphate and absorbable polymers. Also disclosed is a novel controlled release composition of ascorbic acid phosphate made by the method of the present invention.

Abstract: A novel method of preparing a controlled release composition is disclosed. Specifically, the present invention relates to a method of preparing controlled release compositions of ascorbic acid phosphate and absorbable polymers. Also disclosed is a novel controlled release composition of ascorbic acid phosphate made by the method of the present invention.

Abstract: A novel method of preparing a controlled release composition is disclosed. Specifically, the present invention relates to a method of preparing controlled release compositions of ascorbic acid phosphate and absorbable polymers. Also disclosed is a novel controlled release composition of ascorbic acid phosphate made by the method of the present invention.

Abstract: A surgical implant with a basic structure, preferably configured as an implant mesh, contains an anabolic steroid and a corticosteroid. The implant is preferably designed to release these active substances after implantation. It becomes incorporated rapidly and effectively, without any undesired scar contraction occurring.

Abstract: A novel method of preparing a controlled release composition is disclosed. Specifically, the present invention relates to a method of preparing controlled release compositions of ascorbic acid phosphate and absorbable polymers. Also disclosed is a novel controlled release composition of ascorbic acid phosphate made by the method of the present invention.

Abstract: A surgical suture system (1, 21, 41) is illustrated and described. The object, namely to permit simple correction of the suture course or of an incorrect position, is achieved by a suture system (1) with a needle-like applicator (2, 22, 42) having a tip (26, 50) in its front end area, with a surgical suture material (4, 24, 44) provided with barbs (6, 7, 28, 29, 47, 48) which, on one side, preferably point in one direction of action from a reference point (8, 30, 49) and, on the other side, point in the opposite direction of action from the reference point (8, 30, 49) and are designed to block a movement of body tissue (12) away from the reference point (8, 30, 49), and with a sheath (3, 23, 43) whose front end area starts from the rear end area of the applicator (2, 22, 42) and which surrounds the surgical suture material (4, 24, 44).

Abstract: Extending from a point, namely the point of rotation (2), of a surgical hook (1), there are at least two curved arms (4, 5) whose free ends (A, B) each have a tip (6, 7) and which are curved in the same direction of rotation. The arms (4, 5) can be introduced into a patient's tissue by turning the hook (1) about the point of rotation (2). The hook (1) preferably comprises absorbable material, and the arms (4, 5) are preferably provided with barbs (8) which point away from the free ends (A, B) of the arms (4, 5). The hook (1) is suitable for wound closure, including in a vertical direction, and also for fixing of implants.

Abstract: A surgical implant (10) has an areal base structure (12) and at least one projection (14) which is absorbable or partially absorbable and which is designed to take up at least half the implant's own weight of body fluids. In a preferred embodiment, the projection (14) has an attachment area (16) which is sited on the base structure (12) and which is adjoined by a cylindrical or frustoconical middle part (17), pointing away from the base structure (12), followed by a widening (18) arranged at the end remote from the base structure (12).

Abstract: A surgical implant with a basic structure, preferably configured as an implant mesh, contains an anabolic steroid and a corticosteroid. The implant is preferably designed to release these active substances after implantation. It becomes incorporated rapidly and effectively, without any undesired scar contraction occurring.